These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31903176)

  • 21. Downregulation of miR-19a exhibits inhibitory effects on metastatic renal cell carcinoma by targeting PIK3CA and inactivating Notch signaling in vitro.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    Oncol Rep; 2015 Aug; 34(2):739-46. PubMed ID: 26058752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
    Xiao W; Lou N; Ruan H; Bao L; Xiong Z; Yuan C; Tong J; Xu G; Zhou Y; Qu Y; Hu W; Gao Y; Ru Z; Liu L; Xiao H; Chen K; Yang H; Zhang X
    Cell Physiol Biochem; 2017; 43(6):2420-2433. PubMed ID: 29073615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.
    Petrelli A; Carollo R; Cargnelutti M; Iovino F; Callari M; Cimino D; Todaro M; Mangiapane LR; Giammona A; Cordova A; Montemurro F; Taverna D; Daidone MG; Stassi G; Giordano S
    Oncotarget; 2019 Aug; 10(48):5003-5004. PubMed ID: 31452840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: MiR-451 as a new tumor marker for gastric cancer.
    Shen Y; Gong JM; Zhou LL; Sheng JH
    Oncotarget; 2019 Oct; 10(59):6396. PubMed ID: 31695848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
    Lin CY; Hsieh PL; Liao YW; Peng CY; Lu MY; Yang CH; Yu CC; Liu CM
    Oncotarget; 2018 May; 9(37):24870. PubMed ID: 29873328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
    An F; Gong G; Wang Y; Bian M; Yu L; Wei C
    Oncotarget; 2018 May; 9(37):24871. PubMed ID: 29873327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.
    Wang Z; Peng S; Jiang N; Wang A; Liu S; Xie H; Guo L; Cai Q; Niu Y
    Oncotarget; 2018 Nov; 9(91):36406. PubMed ID: 30555638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.
    Zhang X; Yao J; Guo K; Huang H; Huai S; Ye R; Niu B; Ji T; Han W; Li J
    Oncotarget; 2020 Jan; 11(4):490-491. PubMed ID: 32064053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma.
    Boulos S; Park MC; Zeibak M; Foo SY; Jeon YK; Kim YT; Motzik A; Tshori S; Hamburger T; Kim S; Nechushtan H; Razin E
    Oncotarget; 2018 Nov; 9(90):36250. PubMed ID: 30546840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
    Pu Y; Zhao F; Wang H; Cai W; Gao J; Li Y; Cai S
    Oncotarget; 2017 Sep; 8(36):60723. PubMed ID: 28948006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction: Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies.
    Zhang S; Wang Q; He J
    Oncotarget; 2018 Jun; 9(48):29018. PubMed ID: 29989019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc.
    Conde-Muiño R; Cano C; Sánchez-Martín V; Herrera-Merchan A; Comino A; Medina PP; Palma P; Cuadros M
    Oncotarget; 2020 Mar; 11(13):1202. PubMed ID: 32284795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.
    Yang FQ; Zhang HM; Chen SJ; Yan Y; Zheng JH
    PLoS One; 2015; 10(3):e0120258. PubMed ID: 25793370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.
    Liu X; Lei Q; Yu Z; Xu G; Tang H; Wang W; Wang Z; Li G; Wu M
    Oncotarget; 2020 Dec; 11(49):4605-4606. PubMed ID: 33346242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: HIF-1α:CRAT:miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation.
    Song J; Kang YH; Yoon S; Chun CH; Jin EJ
    Oncotarget; 2019 Jul; 10(44):4609-4610. PubMed ID: 31360308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.
    Gordian E; Welsh EA; Gimbrone N; Siegel EM; Shibata D; Creelan BC; Cress WD; Eschrich SA; Haura EB; Muñoz-Antonia T
    Oncotarget; 2021 Jun; 12(13):1325. PubMed ID: 34194632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
    Oncotarget; 2018 Oct; 9(79):35026. PubMed ID: 30405891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways.
    Yang J; Pei H; Luo H; Fu A; Yang H; Hu J; Zhao C; Chai L; Chen X; Shao X; Wang C; Wu W; Wan L; Ye H; Qiu Q; Peng A; Wei Y; Yang L; Chen L
    Oncotarget; 2020 Sep; 11(35):3350-3351. PubMed ID: 32934777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction: Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.
    Ma JW; Hung CM; Lin YC; Ho CT; Kao JY; Way TD
    Oncotarget; 2019 Oct; 10(55):5727-5729. PubMed ID: 31620249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.